Physician profile
Scott Kahn
NPI 1326144387
$3,836.21
in general payments reported to CMS, 2019-2025
46 companies · $608 in 2025
The $608 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $890 · 2020: $228 · 2021: $234 · 2022: $798 · 2023: $488 · 2024: $590 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,650.72 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $522.07 | 2019-2025 | |
| Urogen Pharma, INC. | $317.57 | 2021-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $234.89 | 2019-2025 | Lynparza, Keytruda |
| Janssen Biotech, INC. | $211.24 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $204.65 | 2021-2025 | Spaceoar Vue System - 10ml, Rezum Generator |
| Pfizer INC. | $176.80 | 2019-2025 | |
| Tolmar, INC. | $173.32 | 2023-2025 | Jatenzo, Eligard |
| Astellas Pharma US INC | $158.99 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $123.92 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $103.96 | 2019-2023 | Xiaflex |
| Allergan, INC. | $100.04 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $91.55 | 2023-2025 | Orgovyx, Gemtesa |
| Verity Pharmaceuticals INC. | $87.37 | 2023-2024 | Trelstar |
| Urovant Sciences INC | $82.88 | 2021-2022 | |
| Antares Pharma, INC. | $82.13 | 2023-2025 | Xyosted, Nocdurna, Tlando |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Kahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.